272
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Comparative Evaluation of GeneXpert MTB/RIF Ultra and GeneXpert MTB/RIF for Detecting Tuberculosis and Identifying Rifampicin Resistance in Pars Plana Vitrectomy Samples of Patients with Ocular Tuberculosis

, MD, , MD, DNBORCID Icon, , MS, , MS, , MD, DM, , MSORCID Icon, , MS & , MS show all
Pages 914-920 | Received 15 Jan 2022, Accepted 05 Apr 2022, Published online: 20 Apr 2022

References

  • Biswas J, Kharel R, Multani P. Changing uveitis patterns in South India ‑ Comparison between two decades. Indian J Ophthalmol. 66. 2018:524–527. doi:10.4103/ijo.IJO.
  • Vos AG, Wassenberg MWM, de Hoog J, Oosterheert JJ. Diagnosis and treatment of tuberculous uveitis in a low endemic setting. Int J Infect Dis. 17. 2013:993–999. doi:10.1016/j.ijid.2013.03.019.
  • Gunasekeran DV, Gupta B, Cardoso J, et al. Visual morbidity and ocular complications in presumed intraocular tuberculosis: an analysis of 354 cases from a non-endemic population. Ocul Immunol Inflamm. 2017;1–5. doi:10.1080/09273948.2017.1296580.
  • Krassas N, Wells J, Bell C, et al. Presumed tuberculosis-associated uveitis: rising incidence and widening criteria for diagnosis in a non-endemic area. Eye; 2018;32:87–92. doi:10.1038/eye.2017.152.
  • Basu S, Monira S, Modi RR, et al. Degree, duration, and causes of visual impairment in eyes affected with ocular tuberculosis. J Ophthalmic Inflamm Infect. 2014;4:3. doi:10.1186/1869-5760-4-3.
  • Gupta V, Gupta A, Rao NA. Intraocular Tuberculosis-An Update. Surv Ophthalmol. 2007;52:561–587. doi:10.1016/j.survophthal.2007.08.015.
  • Ang M, Chee SP. Controversies in ocular tuberculosis. Br J Ophthalmol. 2017;101:6–9. doi:10.1136/bjophthalmol-2016-309531.
  • Alvarez GG, Roth VR, Hodge W. Ocular tuberculosis: diagnostic and treatment challenges. Int J Infect Dis. 2009;13:432–435. doi:10.1016/j.ijid.2008.09.018.
  • Gupta A, Bansal R, Gupta V, et al. Ocular Signs Predictive of Tubercular Uveitis. Am J Ophthalmol. 2010;149:562–570. doi:10.1016/j.ajo.2009.11.020.
  • Kataria P, Kumar A, Bansal R, et al. devR PCR for the diagnosis of intraocular tuberculosis. Ocul Immunol Inflamm. 2015;23:47–52. doi:10.3109/09273948.2014.981550.
  • Sharma K, Gupta V, Bansal R, et al. Novel multi-targeted polymerase chain reaction for diagnosis of presumed tubercular uveitis. J Ophthalmic Inflamm Infect. 2013;3(1):25. doi:10.1186/1869-5760-3-25.
  • Sharma M, Singh R, Sharma A, et al. IS1081-based multi-targeted LAMP: an opportunity to detect tubercular uveitis. Ocul Immunol Inflamm. 2020:1–6. doi:10.1080/09273948.2020.1787462.
  • Sharma K, Gupta V, Sharma A, et al. Gene Xpert MTB/RIF assay for the diagnosis of intra-ocular tuberculosis from vitreous fluid samples. Tuberculosis. 2017;102:1–2. doi:10.1016/j.tube.2016.11.002.
  • Sharma K, Gupta A, Sharma M, et al. MTBDRplus for the rapid diagnosis of ocular tuberculosis and screening of drug resistance. EYE. 2017;32:451–453. doi:10.1038/eye.2017.214.
  • Sharma K, Gupta A, Sharma M, et al. The emerging challenge of diagnosing drug-resistant tubercular uveitis: experience of 110 eyes from North India. Ocul Immunol Inflamm. 2021;29:107–114. doi:10.1080/09273948.2019.1655581.
  • Chakravorty S, Simmons AM, Rowneki M, et al. The new Xpert MTB/RIF ultra: improving detection of Mycobacterium tuberculosis and resistance to Rifampin in an assay suitable for point-of-care testing. MBio. 2017;8:1–12. doi:10.1128/mBio.00812-17.
  • World Health Organization. WHO Consolidated Guidelines on Tuberculosis Module 3: Diagnosis; Rapid Diagnostics for Tuberculosis Detection. Geneva: World Health Organization; 2020.
  • Sharma K, Sharma M, Shree R, et al. Xpert MTB/RIF ultra for the diagnosis of tuberculous meningitis: a diagnostic accuracy study from India. Tuberculosis 2020;125:101990. doi:10.1016/j.tube.2020.101990.
  • Kohli M, Schiller I, Dendukuri N, et al. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2021;1:CD012768. doi:10.1002/14651858.CD012768.pub3.
  • Mekkaoui L, Hallin M, Mouchet F, et al. Performance of Xpert MTB/RIF ultra for diagnosis of pulmonary and extra-pulmonary tuberculosis, one year of use in a multi-centric hospital laboratory in Brussels, Belgium. PLoS One. 2021;16:1–15. doi:10.1371/journal.pone.0249734.
  • Gupta A, Sharma A, Bansal R, Sharma K. Classification of intraocular tuberculosis. Ocul Immunol Inflamm. 23. 2015:7–13. doi:10.3109/09273948.2014.967358.
  • Singh R, Gupta V, Gupta A. Pattern of uveitis in a referral eye clinic in north India. Indian J Ophthalmol. 2004;52:121–125. doi:10.1007/BF00175264.
  • British Thoracic Society. 2021. BTS clinical statement for the diagnosis and management of ocular tuberculosis. June. www.brit-thoracic.org.uk›ocular-tb
  • Global Laboratories Initiative core group. 2017 Planning for country transition to Xpert® MTB/RIF ultra cartridges. July. www.stoptb.org›gli›documents›gli_ultra
  • Bahr NC, Nuwagira E, Evans EE, et al. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis. 2018;18:68–75. doi:10.1016/S1473-3099(17)30474-7.
  • Sharma K, Gupta A, Sharma M, et al. Detection of viable Mycobacterium tuberculosis in ocular fluids using mRNA-based multiplex polymerase chain reaction. Indian J Med Microbiol. 2022. doi:10.1016/j.ijmmb.2021.12.019.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.